ARTHROCARE CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-12: Form 8-K; Period of report 2012-12-07; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2012-11-13: Form 8-K; Period of report 2012-11-08; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2012-10-31: Form 8-K; Period of report 2012-10-31; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-09-07: Form 8-K; Period of report 2012-09-06; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-12-12 | 8-K | 2012-12-07 | 7.01 Regulation FD Disclosure | 7.01 On December 7, 2012, James Foster, a member of our Board of Directors, entered into a new prearranged trading plan. | a12-29264_18k.htm |
| 2012-11-13 | 8-K | 2012-11-08 | 7.01 Regulation FD Disclosure | 7.01 On November 8, 2012, Peter Wilson, a member of our Board of Directors, entered into a new prearranged trading plan. | a12-27021_18k.htm |
| 2012-10-31 | 8-K | 2012-10-31 | 2.02 Results of Operations and Financial Condition | 2.02 On October 31, 2012, ArthroCare Corporation issued a press release announcing its financial results for the quarter ended September 30, 2012. | a12-25807_18k.htm |
| 2012-09-07 | 8-K | 2012-09-06 | 7.01 Regulation FD Disclosure | 7.01 On September 6, 2012, David Fitzgerald, our President and Chief Executive Officer and a member of our Board of Directors, entered into a new prearranged trading plan. | a12-20589_18k.htm |
| 2012-08-27 | 8-K | 2012-08-24 | 7.01 Regulation FD Disclosure | 7.01 Effective August 24, 2012, Tord Lendau, a member of our Board of Directors, entered into a new prearranged trading plan to sell 15,000 shares of ArthroCare common stock in one or more open market transactions between September 20, 2012 and May 31, 2013. | a12-18666_18k.htm |
| 2012-08-01 | 8-K | 2012-08-01 | 2.02 Results of Operations and Financial Condition | 2.02 On August 1, 2012, ArthroCare Corporation issued a press release announcing its financial results for the quarter ended June 30, 2012. | a12-17453_18k.htm |
| 2012-06-05 | 8-K | 2012-06-04 | 8.01 Other Events | 8.01 On June 4, 2012, the United States District Court for the Western District of Texas entered a final judgment giving final approval of the settlement in In Re ArthroCare Corporation Securities Litigation, Case No. 1:08-cv-00574-SS (consolidated). | a12-14138_18k.htm |
| 2012-05-29 | 8-K | 2012-05-24 | 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 7.01 On May 25, 2012, Jean Woloszko, our Chief Technology Officer and Senior Vice President of Research and Development, entered into a new prearranged trading plan to sell 97,535 shares of ArthroCare common stock in one or more open market transactions between June 30, 2012 and May 20, 2013. | a12-13173_18k.htm |
| 2012-05-02 | 8-K | 2012-05-02 | 2.02 Results of Operations and Financial Condition | 2.02 On May 2, 2012, ArthroCare Corporation issued a press release announcing its financial results for the quarter ended March 31, 2012. | a12-11137_18k.htm |
| 2012-03-02 | 8-K | 2012-02-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers. 7.01 On February 29, 2012, Peter L. Wilson, a member of our Board of Directors, entered into a prearranged trading plan to exercise options to acquire 15,000 shares and sell 10,000 shares in one or more open market transactions between May 1, 2012 and May 29, 2012. | a12-6364_18k.htm |
| 2012-02-16 | 8-K | 2012-02-16 | 2.02 Results of Operations and Financial Condition | 2.02 On February 16, 2012, ArthroCare Corporation issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2011. | a12-5278_18k.htm |
| 2012-01-20 | 8-K | 2012-01-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (c) On January 17, 2012, the Board of Directors (the “Board”) of ArthroCare Corporation (the “Company”) appointed Todd Newton as the Company’s Chief Operating Officer, effective January 1, 2012. | a12-3192_18k.htm |
| 2012-01-11 | 8-K | 2012-01-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers. | a12-2550_18k.htm |